News · 26 weeks85-26%
2026-04-262026-10-18
Mix4590d
- Insider21(47%)
- Other16(36%)
- SEC Filings3(7%)
- Analyst2(4%)
- Earnings2(4%)
- Leadership1(2%)
Latest news
25 items- INSIDERSEC Form 4 filed by Veeva Systems Inc.4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- PRiOnctura appoints Paul Sekhri as Chair of its Board of DirectorsPaul Sekhri is a life science executive with more than 35 years of experience building and leading companies from early development through commercializationAppointment comes as iOnctura prepares for late-stage development of roginolisib, with its two randomized studies fully enrolledStrengthens iOnctura’s Board with extensive experience in company building, strategic transactions and financing GENEVA, AMSTERDAM and CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) -- iOnctura, a clinical-stage precision oncology company combating neglected and hard-to-treat cancers, today announces the appointment of Paul Sekhri as Chair of its Board of Directors with immediate effect. Paul’s career spa
- PRVeeva to Host Virtual Investor Day on November 5, 2026PLEASANTON, Calif., Oct. 14, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will host its investor day virtually on Thursday, November 5, 2026. The event will begin at 1:30 p.m. PT and will conclude at approximately 3:30 p.m. PT.Veeva will broadcast the presentations live on the company's investor relations website, ir.veeva.com, where a link to the archived webcast will also be available after the event.Event: Veeva Systems' 2026 Investor DayDate: Thursday, November 5, 2026Time: 1:30 p.m. PT (4:30 p.m. ET)Online event registration can be found on the company's investor relations website or directly at this link.Webcast: ir.veeva.comAbout Veeva SystemsVeev
- PRIQVIA Selects Veeva Clinical Operations ApplicationsIQVIA (NYSE:IQV) and Veeva Systems (NYSE:VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications that will be used across IQVIA clinical development studies. This extends the previously announced EDC partnership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261013187834/en/ Together, IQVIA and Veeva bring best-in-class capabilities to clinical research to help customers increase trial speed and efficiency, strengthen site centricity, and make better-informed decisions, ultimately helping get life-changing treatments to p
- PRVeeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and QualityEli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturingPLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit on October 20-21 in Boston, Veeva Systems (NYSE:VEEV) will bring together leading biopharmas, emerging biotechs, CROs, and sites — including Duke University, Eli Lilly and Company, Pfizer, Sanofi, Tolmar, UCB, and the University of Pennsylvania — to explain how they are driving new ways of working across drug development and quality.Veeva will share its vision to power agentic biopharma for the industry with deep AI for clinical, regulatory, safety, and quali
- PREmerging Biotechs Standardize on Veeva Basics to Accelerate Drug DevelopmentMore than 175 biotechs use pre-configured applications to streamline operationsPLEASANTON, Calif., Oct. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that more than 175 emerging biotechs are establishing a technology foundation with Veeva Basics. Biotechs are launching pre-configured and pre-validated Veeva Basics applications in weeks, adding systems that can scale as they move from startup to commercialization. Veeva Basics delivers unified, end-to-end applications for clinical, regulatory, quality, medical, and commercial, enabling high-growth companies to speed innovation while saving time, effort, and cost."As a growing company with under 40 employees, we're focused
- PRVeeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 StudiesAutomates data reconciliation, saving clinical teams significant cost, time, and effortPLEASANTON, Calif., Oct. 6, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that Veeva DQS (Data Quality System) has aggregated and cleaned data for more than 1 million subjects in more than 1,000 studies to accelerate the delivery of analysis-ready data and trial insights. With more than 500,000 automated queries, Veeva DQS has saved thousands of hours in data reconciliation for sites and sponsors."One key area for us is handling the increasing volume of data generated from our growing number of clinical trials," said Ibrahim Kamstrup-Akkaoui, vice president at Novo. "Veeva DQS can help us
- INSIDERSEC Form 4 filed by Veeva Systems Inc.4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- INSIDERSEC Form 4 filed by Veeva Systems Inc.4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- INSIDERSEC Form 4 filed by Veeva Systems Inc.4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- INSIDERSEC Form 4 filed by Veeva Systems Inc.4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- INSIDERSEC Form 4 filed by Veeva Systems Inc.4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- INSIDERSEC Form 4 filed by Veeva Systems Inc.4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- PRServier Adopts Veeva OpenData Globally to Scale AIEstablishing an AI-ready data foundation in more than 80 countriesPLEASANTON, Calif., Sept. 30, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that Servier is standardizing customer reference data across more than 80 countries with Veeva OpenData. Building on its global success with Veeva Link Key People, a leading French pharmaceutical company governed by a Foundation, is harmonizing customer reference data and creating a unified foundation to scale AI."By centralizing our customer reference data through Veeva OpenData, we aren't just improving our current processes, we are building the global, AI-ready data foundation that will redefine how we work," said Liam Hanrahan, di
- PRNew Veeva Study Builder Agent to Configure Clinical Studies in as Little as One DayStandards-first agent delivers faster and more consistent EDC and DQS buildsPLEASANTON, Calif., Sept. 24, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly from a study protocol. By reusing an organization's existing standards and leveraging the CDISC Unified Study Definitions Model (USDM), the agent ensures faster, more deterministic study builds. Study Builder Agent configures EDC forms, visits, and edit check rules, as well as CQL-based listings in DQS. It also automates testing, including the gene
- PRVault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses VeevaWith 190 live customers and 14 top 20 biopharma commitments,Vault CRM is the fastest path to AIPLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced a new top 20 biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly and Company, and Regeneron. With more than 190 live customers and global commitments from 14 of the top 20 biopharmas, Vault CRM is the next generation of CRM, delivering new agentic and core capabilities to increase field productivity and effectiveness. As a foundation for agentic commercial, Vault CRM is helping to transform how the industry engages he
- INSIDERNew insider Rizzo Daniel J claimed ownership of 11,688 shares (SEC Form 3)3 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- PRVeeva Introduces Falcon Router for Agentic Triage of All Reporting ChannelsPLEASANTON, Calif., Sept. 21, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced Veeva Falcon Router, an industry-specific agent to identify and route potential safety adverse event reports, product quality complaints, and medical inquiries to the correct teams with speed and consistency.Falcon Router will orchestrate triage and routing actions for biopharmas of all sizes, without the need for manual reconciliation. The initial focus will be on email and web intake, including Veeva Ostro. Falcon Router will route triaged information directly to Veeva Safety, Veeva QMS, Veeva MedInquiry, or designated inboxes."Every biopharma faces this routing challenge, and it grows with every n
- INSIDERPres. & Chief Customer Officer Schwenger Thomas D. sold $265,200 worth of shares (1,000 units at $265.20) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 18,449 units (SEC Form 4)4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- PRLeading Biotech Selects Veeva Vault CRM GloballyAgentic CRM foundation to help accelerate the delivery of innovative medicines to patients worldwidePLEASANTON, Calif., Sept. 15, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that Amgen plans to deploy Veeva Vault CRM globally, building on a collaboration spanning more than a decade. "Moving to Vault CRM will help accelerate our efforts to bring new therapies to patients globally with greater speed and agility," said Scott Skellenger, senior vice president and chief information officer at Amgen. "Veeva's deep understanding of life sciences, its continued focus on innovation, and our long-standing collaborati
- INSIDERDirector Hung Priscilla sold $195,780 worth of shares (750 units at $261.04), decreasing direct ownership by 19% to 3,242 units (SEC Form 4)4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- INSIDERDirector Sekhri Paul J converted options into 460 shares, increasing direct ownership by 3% to 15,651 units (SEC Form 4)4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- INSIDERDirector Ritter Gordon disposed of 250,000 shares, acquired 15,585 shares and converted options into 541 shares, increasing direct ownership by 91% to 1,136 units (SEC Form 4)4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- INSIDERDirector Wallach Matthew J converted options into 460 shares, increasing direct ownership by 0.43% to 107,393 units (SEC Form 4)4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
- INSIDERDirector Carges Mark T converted options into 493 shares (SEC Form 4)4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
VEEV FAQ
7 questionsWhat does Veeva Systems Inc. do?
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva Andi, Veeva OpenData, Veeva Link, Veeva Network Customer Master, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Doctors; and Veeva...Where does VEEV stock trade?
Veeva Systems Inc. (VEEV) is listed on NYSE.What sector and industry is VEEV in?
Veeva Systems Inc. operates in the Technology sector, Computer Software: Prepackaged Software industry.When did Veeva Systems Inc. go public?
Veeva Systems Inc. (VEEV) completed its IPO in 2013.What are analysts saying about VEEV?
Veeva Systems Inc. has had 8 recent analyst actions on file. The most recent action was from Piper Sandler: Overweight on 2026-08-24.What companies are similar to VEEV?
Notable peers in the same industry include MSFT (Microsoft Corporation), ORCL (Oracle Corporation), SAP (SAP SE), CRWD (CrowdStrike Holdings Inc.), CRM (Salesforce Inc.). Compare VEEV side-by-side with any of them on Quantisnow.How can I track VEEV on Quantisnow?
Quantisnow aggregates Veeva Systems Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VEEV to receive live email and push alerts on every new disclosure.